Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It also provides diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, emerging retail healthcare providers, pharmaceutical companies and insurers, commercial clinical laboratories, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. In addition, the company offers risk assessment services for the life insurance industry; and healthcare organizations and clinicians information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.

Quest Diagnostics Incorporated

In a report released today, Scot Ciccarelli from Truist Financial maintained a Hold rating on Dollar General, with a price target of $138.00. Cicca...

Truist Financial Reaffirms Their Hold Rating on Dollar General (DG)

Oppenheimer analyst Rupesh Parikh maintained a Buy rating on Dollar General today and set a price target of $150.00. According to TipRanks, Parikh ...

Oppenheimer Keeps Their Buy Rating on Dollar General (DG)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Quest Diagnostics (DGX) and Irhythm Technologies (IR...

Analysts Offer Insights on Healthcare Companies: Quest Diagnostics (DGX) and Irhythm Technologies (IRTC)

Integrated Diagnostics Holdings ( ($GB:IDHC) ) just unveiled an update. Integrated Diagnostics Holdings disclosed a transaction involving Hena Hold...

Integrated Diagnostics Discloses Mandatory Offer Acceptance by CEO-Linked Investor

An announcement from China Dongxiang (Group) Co ( ($HK:3818) ) is now available. China Dongxiang (Group) Co., Ltd. has announced a delay in sending...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	DGX	$237.14	-0.94%	775.42K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	DGX	$237.14	-0.9%	775.42K
3
4
5
6

DGX

Get Quest Diagnostics Incorporated Data in Excel

Get Quest Diagnostics Incorporated Data in Excel